Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 19 studies | 91% ± 10% | |
oligodendrocyte | 16 studies | 80% ± 18% | |
oligodendrocyte precursor cell | 16 studies | 82% ± 23% | |
endothelial cell | 13 studies | 37% ± 17% | |
GABAergic neuron | 11 studies | 73% ± 21% | |
glutamatergic neuron | 11 studies | 54% ± 24% | |
microglial cell | 11 studies | 36% ± 18% | |
macrophage | 9 studies | 30% ± 12% | |
fibroblast | 8 studies | 29% ± 11% | |
adipocyte | 7 studies | 33% ± 11% | |
endothelial cell of lymphatic vessel | 7 studies | 40% ± 9% | |
interneuron | 6 studies | 58% ± 28% | |
pericyte | 5 studies | 24% ± 6% | |
smooth muscle cell | 5 studies | 30% ± 9% | |
neuron | 4 studies | 50% ± 15% | |
cardiac muscle cell | 4 studies | 20% ± 1% | |
Mueller cell | 4 studies | 52% ± 17% | |
retina horizontal cell | 4 studies | 55% ± 14% | |
GABAergic interneuron | 3 studies | 65% ± 27% | |
mesothelial cell | 3 studies | 50% ± 24% | |
ciliated cell | 3 studies | 17% ± 1% | |
GABAergic amacrine cell | 3 studies | 30% ± 9% | |
retinal ganglion cell | 3 studies | 46% ± 16% | |
retinal pigment epithelial cell | 3 studies | 38% ± 9% | |
neural progenitor cell | 3 studies | 48% ± 35% | |
ependymal cell | 3 studies | 91% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2107.00 | 2638 / 2642 | 100% | 35.55 | 702 / 705 |
ovary | 96% | 414.36 | 172 / 180 | 90% | 9.82 | 385 / 430 |
thymus | 85% | 260.98 | 553 / 653 | 76% | 3.74 | 461 / 605 |
uterus | 72% | 232.94 | 123 / 170 | 13% | 1.59 | 60 / 459 |
breast | 51% | 143.59 | 234 / 459 | 13% | 0.59 | 146 / 1118 |
esophagus | 57% | 179.92 | 823 / 1445 | 4% | 0.17 | 8 / 183 |
adrenal gland | 57% | 145.75 | 146 / 258 | 4% | 0.18 | 10 / 230 |
intestine | 60% | 207.95 | 577 / 966 | 1% | 0.02 | 4 / 527 |
prostate | 49% | 131.73 | 120 / 245 | 2% | 0.12 | 11 / 502 |
kidney | 44% | 100.64 | 39 / 89 | 7% | 0.28 | 66 / 901 |
spleen | 40% | 102.28 | 96 / 241 | 0% | 0 | 0 / 0 |
adipose | 38% | 97.80 | 459 / 1204 | 0% | 0 | 0 / 0 |
stomach | 28% | 81.00 | 102 / 359 | 2% | 0.12 | 7 / 286 |
skin | 2% | 4.24 | 37 / 1809 | 25% | 1.18 | 116 / 472 |
bladder | 14% | 33.71 | 3 / 21 | 3% | 0.28 | 15 / 504 |
eye | 0% | 0 | 0 / 0 | 14% | 0.43 | 11 / 80 |
blood vessel | 13% | 28.30 | 177 / 1335 | 0% | 0 | 0 / 0 |
lung | 1% | 2.23 | 5 / 578 | 7% | 0.64 | 83 / 1155 |
pancreas | 1% | 2.41 | 4 / 328 | 5% | 0.19 | 9 / 178 |
heart | 1% | 2.19 | 10 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | NPAS3 |
Protein name | Neuronal PAS domain protein 3 isoform G Neuronal PAS domain protein 3 isoform A Neuronal PAS domain protein 3 Neuronal PAS domain protein 3 isoform F Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6) Neuronal PAS domain protein 3 isoform C Neuronal PAS domain protein 3 isoform D Neuronal PAS domain protein 3 isoform B Neuronal PAS domain protein 3 isoform E Neuronal PAS domain protein 3 isoform H Neuronal PAS domain protein 3 isoform I |
Synonyms | BHLHE12 PASD6 MOP6 |
Description | FUNCTION: May play a broad role in neurogenesis. May control regulatory pathways relevant to schizophrenia and to psychotic illness (By similarity). . |
Accessions | Q8IXF0 ENST00000551634.6 H0YHU7 X5D988 X5DR67 ENST00000552874.1 ENST00000552696.1 X5DRK2 ENST00000357798.9 [Q8IXF0-3] X5DNV7 ENST00000356141.9 [Q8IXF0-1] X5D9I7 ENST00000680362.1 X5DRF3 ENST00000551492.5 F8W0C2 X5D985 A0A7P0T8Q6 ENST00000681323.1 H0YI42 A0A7P0TA87 F8VS42 ENST00000548645.5 [Q8IXF0-2] ENST00000346562.6 [Q8IXF0-4] H0YHB6 X5D7M0 X5D2Q4 F8VR32 ENST00000547068.5 [Q8IXF0-5] ENST00000546849.1 ENST00000551008.6 |